Now children have also joined the people who have taken advantage of Vaccination to avoid Corona. It originated in the US, where the US Food and Drug Administration has approved the Pfizer-Biontech Vaccine for children 12 years or older. After this decision, it is believed that the pace of vaccination will increase in the country. In the coming time, it is expected to get approval for this vaccine for children in India too. Children are far behind in the link of availing Vaccine, so questions are arising that how will this vaccine work on children?
The Pfizer vaccine trial was conducted on 2,260 children, aged between 12 and 15 years. In this trial, the FDA found the vaccine safe and effective. Half the children were given the same dose as the adults in the trial. Some children felt side effects such as headaches and fever but were cured with common medicines. On the scale of safety, this vaccine was found to be similar to those between 16 and 25 years old.
Vaccine is necessary for children too
Children are generally reported to be at less risk of infection than older ones, but the vaccine is also necessary for children. Even if they do not have any kind of serious disease, but minor diseases can work as conductors of any serious disease. In many cases, epidemics have also engulfed children. At the same time, many such strains have also emerged which treat children like elders.
No separate arrangement for children
In America, children 12 years or older will now be vaccinated, but no special preparations have been made for this. Vaccine will be given to these children in the same places and pharmacy where the elders are being given. Let me tell you that till now only Pfizer-Bioentech vaccine has been approved to be given to children below 18 years of age.
Vaccine will also be given in these countries
In addition to the United States, Canada and Algeria have also been approved to give this vaccine to children. The company said that it has given data to other countries for approval as well. A committee of experts from India has called for the second and third phase trials of Bharat Biotech vaccine for children aged 2 to 18 years.
The postappeared first on .